Drug Therapy Reduces HIV Transmission in Couples Regardless of Condom Use or Safe-Sex Practices

Feb 11, 2009

(PhysOrg.com) -- Antiretroviral drug therapy in an HIV-positive man or women can alone help prevent the transmission of HIV to an uninfected partner, regardless of counseling, the patient’s use of condoms or other safe-sex practices, AIDS experts at Johns Hopkins report.

In a study among 205 so-called discordant couples in Uganda, in which only one member of each heterosexual pair was infected with HIV, researchers found that not a single case of transmission from one partner to the other occurred when the infected man or women was taking potent anti-HIV medications to keep the disease in check.

By contrast, 34 men and women became infected among the 185 remaining couples in which neither partner was taking antiretroviral therapy. The study group pairs consisted of 126 HIV-positive men and 79 HIV-positive women.

The experts caution that drug therapy should not be considered a fail-safe strategy in such couples and that condom use and safe-sex practices are still vitally important. But the results, they say, show that the drugs significantly help lower the risk of transmission.

According to lead study investigator and infectious diseases specialist Steven Reynolds, M.D., M.P.H., the study results show that antiretroviral therapy not only “treats the HIV-infected member of a discordant couple,” but also plays some role in preventing the virus from spreading.

However, he cautions that its preventive role is limited because of the advanced stage of disease in those being treated in his study group. In Uganda, as in most countries, infected people usually do not qualify for government-funded antiretroviral therapies until the disease has reached an advanced stage, with a CD4 immune system cell count of 200 or less.

Reynolds, an assistant professor at the Johns Hopkins University School of Medicine and a staff clinician at the U.S. National Institute for Allergy and Infectious Diseases, says study results showed that HIV transmission in the treated couples was prevented despite the failure of counseling to halt unsafe sex practices, such as extramarital sex or failure to use condoms.

Participants in the study, conducted jointly by Johns Hopkins and Rakai Health Sciences Program researchers between 2004 and 2007, came from the Rakai cohort, a population of 12,000 people in Uganda who are being monitored to determine how HIV spreads throughout the country. The researchers based their findings on extensive interviews with each participant and an annual check-up during which blood tests were conducted.

Antiretroviral therapy reduced the rate of sexual transmission of HIV among HIV discordant couples in rural Rakai, Uganda, by Steven Reynolds, Frederick Makumbi, Joseph Kagaayi, Gertrude Nakigozi, Ronald Galiwongo, Thomas Quinn, Maria Wawer, Ronald Gray and David Serwadda.

Provided by Johns Hopkins University

Explore further: Integrating mental health care into HIV care

add to favorites email to friend print save as pdf

Related Stories

Gold nanoparticles: A new delivery for cancer drugs

May 08, 2013

(Phys.org) —The protein tumor necrosis factor-alpha (TNF-alpha) is a powerful weapon in the arsenal to control cancer. Unfortunately, as is the case with many potent cancer therapies, the use of TNF-alpha as an anti-cancer ...

Recommended for you

Integrating mental health care into HIV care

1 hour ago

The integration of mental health interventions into HIV prevention and treatment platforms can reduce the opportunity costs of care and improve treatment outcomes, argues a new Policy Forum article published in this week's ...

After a decade, global AIDS program looks ahead

14 hours ago

(AP)—The decade-old law that transformed the battle against HIV and AIDS in developing countries is at a crossroads. The dream of future generations freed from the epidemic is running up against an era ...

AIDS science at 30: 'Cure' now part of lexicon

May 18, 2013

Big names in medicine are set to give an upbeat assessment of the war on AIDS on Tuesday, 30 years after French researchers identified the virus that causes the disease.

User comments : 0

More news stories

Reducing caloric intake delays nerve cell loss

Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...

Biomarkers discovered for inflammatory bowel disease

Using the Department of Defense Serum Repository (DoDSR), University of Cincinnati (UC) researchers have identified a number of biomarkers for inflammatory bowel disease (IBD), which could help with earlier diagnosis and ...

Changing cancer's environment to halt its spread

By studying the roles two proteins, thrombospondin-1 and prosaposin, play in discouraging cancer metastasis, a trans-Atlantic research team has identified a five-amino acid fragment of prosaposin that significantly reduces ...

Global recommendations on child medicine

Transparent information on the evidence supporting global recommendations on paediatric medicines should be easily accessible in order to help policy makers decides on what drugs to include in their national drug lists, according ...

Power of US tornado dwarfs Hiroshima bomb

Wind, humidity and rainfall combined precisely to create Monday's massive killer tornado in Oklahoma. The awesome amount of energy released dwarfed the power of the atomic bomb that leveled Hiroshima.